Abstract
PurposeThe antidiabetic thiazolidinedione medications activate the peroxisome proliferator-activated receptor gamma (PPARγ) and exert vascular protective effects through incompletely defined mechanisms. We recently reported that the PPARγ ligands 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
More From: Journal of Investigative Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.